Captrust Financial Advisors Takes Position in Addus HomeCare Co. (NASDAQ:ADUS)

Captrust Financial Advisors purchased a new position in shares of Addus HomeCare Co. (NASDAQ:ADUS) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 2,944 shares of the company’s stock, valued at approximately $392,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Point72 Asset Management L.P. grew its holdings in Addus HomeCare by 73.4% during the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock worth $86,598,000 after acquiring an additional 315,602 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Addus HomeCare by 0.8% in the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after purchasing an additional 5,421 shares during the last quarter. Principal Financial Group Inc. increased its holdings in Addus HomeCare by 17.5% in the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock valued at $67,293,000 after purchasing an additional 75,409 shares during the period. WCM Investment Management LLC raised its position in Addus HomeCare by 2.9% during the 3rd quarter. WCM Investment Management LLC now owns 498,279 shares of the company’s stock worth $65,250,000 after purchasing an additional 13,938 shares during the last quarter. Finally, Millennium Management LLC lifted its holdings in Addus HomeCare by 412.7% during the 2nd quarter. Millennium Management LLC now owns 316,418 shares of the company’s stock worth $36,739,000 after buying an additional 254,705 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

Insiders Place Their Bets

In related news, CEO R Dirk Allison sold 12,500 shares of Addus HomeCare stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the transaction, the chief executive officer now owns 141,897 shares of the company’s stock, valued at $17,476,034.52. The trade was a 8.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Roberton James Stevenson sold 2,250 shares of the firm’s stock in a transaction on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the transaction, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 4.60% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on ADUS. Oppenheimer raised their price objective on Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research report on Monday, September 23rd. Royal Bank of Canada restated an “outperform” rating and set a $136.00 price target on shares of Addus HomeCare in a report on Thursday, November 14th. StockNews.com raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research note on Wednesday. Stephens lifted their target price on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 6th. Finally, KeyCorp initiated coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They set an “overweight” rating and a $150.00 price target on the stock. One research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Addus HomeCare has an average rating of “Moderate Buy” and an average price target of $131.63.

Addus HomeCare Price Performance

ADUS stock opened at $125.00 on Friday. The company’s 50-day moving average is $125.64 and its 200-day moving average is $124.37. Addus HomeCare Co. has a 1 year low of $85.94 and a 1 year high of $136.12. The stock has a market capitalization of $2.27 billion, a PE ratio of 28.60, a price-to-earnings-growth ratio of 2.11 and a beta of 1.01.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, November 4th. The company reported $1.30 EPS for the quarter, beating the consensus estimate of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. During the same quarter in the previous year, the company posted $1.03 earnings per share. The company’s quarterly revenue was up 7.1% on a year-over-year basis. On average, analysts anticipate that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.